Drug intelligence / Profile preview

mimosine

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Mimosine is a non-proteinogenic amino acid and a structural analog of tyrosine that is naturally found in certain plants such as Mimosa species and all members of the genus Leucaena. It acts primarily as an iron/zinc chelator and exerts its biological effects by inhibiting DNA replication. Mimosine induces cell cycle arrest in late G1 phase by preventing the initiation or elongation of DNA replication through inhibition of ribonucleotide reductase (an iron-dependent enzyme) and suppression of serine hydroxymethyltransferase gene transcription. This leads to DNA double-strand breaks and activation of the DNA damage response pathway. Mimosine has been studied for its antitumor/antiproliferative properties as well as potential anti-inflammatory, antifungal, antiviral, herbicidal/insecticidal activities. It is used experimentally in research settings for cell cycle synchronization and plant growth regulation[1][2][5].

Other names
L-mimosine(L)-mimosine(S)-2-amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoateleucaenineleucaenolleucenineleucenolmimosin
02

Targets

NeuraminidaseRNR (Ribonucleotide reductase)SHMT2 (Serine hydroxymethyltransferase 2)TYR (Tyrosinase)

Beyond the preview

Go deeper on mimosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mimosine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call